SCHEMBL4013274

SCHEMBL4013274

Cc1ccc(N)cc1N(C(N)=O)C(C)C

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CASP1 P29466 2/20 0.40
▸ TSHR P16473 2/20 0.40
▸ ALDH1A1 P00352 3/20 0.39
▸ NPC1 O15118 1/20 0.38
▸ MITF O75030 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ CYP3A4 P08684 2/20 0.36
▸ PDE10A Q9Y233 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ MAPT P10636 2/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ RECQL P46063 1/20 0.35
▸ ALOX5 P09917 4/20 0.34
▸ PKM P14618 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10363554 0.85 ALOX5 (0.41) ALDH1A1POLBL3MBTL1CYP2C19ALOX5
SCHEMBL10364141 0.81 ALDH1A1 (0.49) CASP1ALDH1A1LMNAPOLBCYP3A4
SCHEMBL4209917 0.81 GRM1 (0.46) TSHRPOLBL3MBTL1CYP1A2RECQL
SCHEMBL6682382 0.72 CASP1 (0.45) CASP1TSHRALDH1A1NPC1MITF
SCHEMBL18147661 0.70 CASP1 (0.44) CASP1TSHRALDH1A1NPC1MITF
SCHEMBL11287375 0.70 CASP1 (0.37) CASP1TSHRALDH1A1NPC1MITF
SCHEMBL11495612 0.69 TSHR (0.42) CASP1TSHRALDH1A1LMNAPOLB
SCHEMBL18509676 0.69 ALDH1A1 (0.50) CASP1TSHRALDH1A1NPC1MITF
SCHEMBL18332397 0.68 L3MBTL1 (0.48) CASP1TSHRALDH1A1NPC1LMNA
SCHEMBL865227 0.68 ALDH1A1 (0.54) CASP1TSHRALDH1A1NPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009089042-A1 PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC (US) 2009-07-16 — — WO disclosed
Send feedback